ClearPoint Neuro Inc. (CLPT) Q4 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings. Welcome to ClearPoint Noro, Inc., fourth quarter and full year 2024 conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance, please press star zero on your telephone keypad. As a reminder, this conference call is being recorded. Comments made on this call may include statements that are forward-looking within the meaning of the security laws. These forward-looking statements may include, without limitation, statements related to anticipated industrial trends, the company's plans, prospects, strategies, both preliminary and projected, the size of total addressable markets, or the market opportunity for the company's products and services, the management's expectations, beliefs, estimates, or projections regarding future revenue. results of operation or adequacy of cash and cash equivalent balances to support operations and meet future obligations. Actual results or trends could differ materially. The company undertakes no obligation to revise forward-looking statements for new information or future events. For more information, please refer to the company's annual report on forum information. 10-K for the year ended December 31, 2023. The company's quarterly report on Form 10-Q for three months ended September 30, 2024, both of which have been filed with the Securities and Exchange Commissions. And the company's annual report on Form 10-K for the year ended December 31, 2024, which the company intends to file with the Securities and Exchange Commission on or before March 31st, 2025. All of the company's filings may be obtained from the SEC or the company's website at www.clearpointneuro.com. It is now my pleasure to introduce Jo...